Evidence map›Paper›PMID 28087734›Full record

ArticleHuman molecular genetics2017

Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients.

Doriana Borgia, Adriana Malena, Marco Spinazzi, Maria Andrea Desbats, Leonardo Salviati, Aaron P Russell, Giovanni Miotto, Laura Tosatto, Elena Pegoraro, Gianni Sorarù and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Doriana BorgiaDepartment of Neurosciences, University of Padova, Padova, Italy.
Adriana MalenaDepartment of Neurosciences, University of Padova, Padova, Italy.
Marco SpinazziVIB Center for the Biology of Disease, KU Leuven Center for Human Genetics, Leuven, Belgium.
Maria Andrea DesbatsClinical Genetics Unit, Department of Woman and Child Health, University of Padova, Padova, Italy, and IRP Città della Speranza, Padova, Italy.
Leonardo SalviatiClinical Genetics Unit, Department of Woman and Child Health, University of Padova, Padova, Italy, and IRP Città della Speranza, Padova, Italy.
Aaron P RussellInstitute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Burwood, Australia.
Giovanni MiottoDepartment of Molecular Medicine, University of Padova, Padova, Italy.
Laura TosattoDulbecco Telethon Institute, Centre for Integrative Biology, University of Trento, Trento, Italy.
Elena PegoraroDepartment of Neurosciences, University of Padova, Padova, Italy.
Gianni SorarùDepartment of Neurosciences, University of Padova, Padova, Italy.
Maria PennutoDulbecco Telethon Institute, Centre for Integrative Biology, University of Trento, Trento, Italy.
Lodovica VerganiDepartment of Neurosciences, University of Padova, Padova, Italy.
University of Padua · ITCittà della Speranza Foundation · ITDeakin University · AUDulbecco Telethon Institute · ITUniversity of Trento · ITVIB-KU Leuven Center for Cancer Biology · BE

Funding

Telethon TCP12013
6 · The paper itself

Abstract

Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder caused by polyglutamine expansion in the androgen receptor (AR) and characterized by the loss of lower motor neurons. Here we investigated pathological processes occurring in muscle biopsy specimens derived from SBMA patients and, as controls, age-matched healthy subjects and patients suffering from amyotrophic lateral sclerosis (ALS) and neurogenic atrophy. We detected atrophic fibers in the muscle of SBMA, ALS and neurogenic atrophy patients. In addition, SBMA muscle was characterized by the presence of a large number of hypertrophic fibers, with oxidative fibers having a larger size compared with glycolytic fibers. Polyglutamine-expanded AR expression was decreased in whole muscle, yet enriched in the nucleus, and localized to mitochondria. Ultrastructural analysis revealed myofibrillar disorganization and streaming in zones lacking mitochondria and degenerating mitochondria. Using molecular (mtDNA copy number), biochemical (citrate synthase and respiratory chain enzymes) and morphological (dark blue area in nicotinamide adenine dinucleotide-stained muscle cross-sections) analyses, we found a depletion of the mitochondria associated with enhanced mitophagy. Mass spectrometry analysis revealed an increase of phosphatidylethanolamines and phosphatidylserines in mitochondria isolated from SBMA muscles, as well as a 50% depletion of cardiolipin associated with decreased expression of the cardiolipin synthase gene. These observations suggest a causative link between nuclear polyglutamine-expanded AR accumulation, depletion of mitochondrial mass, increased mitophagy and altered mitochondrial membrane composition in SBMA muscle patients. Given the central role of mitochondria in cell bioenergetics, therapeutic approaches toward improving the mitochondrial network are worth considering to support SBMA patients.

Indexed as

AdultAgedAged, 80 and overAmyotrophic Lateral SclerosisAndrogensAnimalsBiopsyDNA, MitochondrialFemaleHumansMaleMiddle AgedMitophagyMotor NeuronsMuscle, SkeletalMuscular Disorders, AtrophicAndrogensDNA, MitochondrialPeptidespolyglutamineReceptors, Androgen

Identifiers

PMID28087734
PMCPMC5409076
OpenAlexW2572299205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.